Sales of adult-use cannabis in Illinois totaled more than $37 million in April as recreational marijuana retailers enjoyed status as essential businesses in the face of the ongoing coronavirus pandemic. Officials with the Illinois Department of Financial and Professional Regulation (IDFPR) announced on Monday that preliminary figures for adult-use cannabis retail sales came to $37,260,497.89 in April, the fourth month of the state’s newly legal recreational marijuana industry.
USDA Unveils Guidelines For Federal Loans To Hemp Business
The U.S. Department of Agriculture (USDA) recently released guidelines for processing federal loans for the hemp industry. Since hemp was federally legalized under the 2018 Farm Bill, it is now considered an agricultural commodity like any other crop...
Trump Admin Could Let Researchers Study Marijuana Dispensary Products, Scientist Argues After DOJ Memo Released
A scientist in a case that forced the release of a previously “secret” Justice Department document about federally authorized marijuana research this week is now calling on Congress to urge administrative action to more rapidly expand studies into the therapeutic potential of cannabis.
Marijuana Seems To Reduce Opioid Use Among Chronic Pain Patients, Meta-Study Finds
Legalization advocates have long argued that marijuana represents a potentially effective treatment option for chronic pain and could serve as an alternative to opioid-based painkillers—and according to a new scientific meta-analysis, they may be onto something.
Cresco Labs Secures Debt Funding up to US$200 Million
Cresco Labs has announced non-dilutive debt financing of US$100 million, with an option to increase to US$200 million.
Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
In a "bad" year for the emerging cannabis industry, global cannabis sales rose by 48% in 2019. That's not bad.
InMed First To Take Cannabinol To Clinical Trials
InMed Pharmaceuticals has isolated the rare cannabinoid, cannabinol, in two cannabinoid-based drugs currently in clinical trials.
Is CBD ‘Harmful’ to Our Liver? No.
The U.S. Food and Drug Administration is claiming that CBD poses significant risks to the human liver. Nonsense.
Industry Leaders Leading Turnaround in Marijuana Stocks?
The largest U.S.-based cannabis company and the largest Canadian cannabis company have both seen their stock make strong moves. Will other cannabis companies follow?
The Best Value in Canadian Cannabis Retail Today?
As Canadian cannabis retailers gather momentum, Choom Holdings provides investors with a very attractive value proposition.
Aphria Produces Third Quarter of Positive EBITDA, Misses on Revenue
Aphria disappointed slightly on Q2 revenue and its stock is trading lower. Investors may see a buying opportunity here.
Tetra Bio-Pharma Receives ‘Favorable Letter of Advice’ From FDA On Botanical Pain Drug
Tetra Bio-Pharma takes another step forward in bringing a botanical cannabinoid drug to market for pain relief.
Fire & Flower Reaches Milestone With 46th Cannabis Store
Fire & Flower Holdings is Canada's new retailing leader in stores as it reports opening its 46th cannabis store.
FDA Gives MJ Testing Companies A Boost With New Exemption
The Food and Drug Administration (FDA) recently announced a policy change that will expedite the marketing of marijuana testing devices if they’re used for certain purposes.
The U.S. Cannabis Revolution: Two Charts
As the U.S. Cannabis Revolution unfolds, over 90% of Americans now want cannabis legalized (at least) for medical purposes. Attention Congress.